XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
OPERATING ACTIVITIES:            
Net loss $ (1,773)   $ (6,270) $ (10,564) $ (66,857)  
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:            
Depreciation and amortization       1,279 3,416  
Provision (recovery) for sales returns       86 (215)  
Amortization of deferred financing cost and debt discounts       160 321  
Stock-based compensation       6,394 6,771  
Change in deferred tax expense       (5) 0  
Change in inventory provisions       (1,653) 213  
Change in fair value of warrant liabilities (161)   (567) (730) (2,410)  
Impairment of Intangible Assets, Finite-Lived 0   0 0 39,445 $ 39,728 [1]
Allowance for credit losses       59  
Changes in assets and liabilities:            
Accounts receivable       966 1,186  
Inventory       5,482 11,960  
Prepaid and other current assets       486 1,942  
Accounts payable, accrued and other liabilities       273 (4,289)  
Cash (used in) provided by operating activities       2,174 (8,458)  
INVESTING ACTIVITIES:            
Purchase of fixed assets       (42) (80)  
Purchase of Step and Go assets       (125)  
Purchase of minority equity investment       (200) 0  
Cash used in investing activities       (242) (205)  
FINANCING ACTIVITIES:            
Repayments on note payable to Smash       (633) (518)  
Borrowings from MidCap credit facilities       44,386 63,978  
Repayments for MidCap credit facilities       (48,976) (71,165)  
Insurance obligation payments       (498) (788)  
Insurance financing proceeds       986  
Cash used in financing activities       (5,721) (7,507)  
Foreign currency effect on cash, cash equivalents, and restricted cash       313 42  
Net change in cash and restricted cash for the year       (3,476) (16,128)  
Cash and restricted cash at beginning of year   $ 30,501   22,195 46,629 46,629
Cash and restricted cash at end of year 18,719 22,195 30,501 18,719 30,501 22,195
RECONCILIATION OF CASH AND RESTRICTED CASH:            
Cash 16,071   27,955 16,071 27,955  
Restricted Cash—Prepaid and other current assets 2,519   2,417 2,519 2,417  
Restricted cash—Other non-current assets 129 100 129 129 129 100
TOTAL CASH AND RESTRICTED CASH $ 18,719 $ 22,195 $ 30,501 18,719 30,501 $ 22,195
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION            
Cash paid for interest       966 1,457  
Cash paid for taxes       151 90  
NON-CASH INVESTING AND FINANCING ACTIVITIES:            
Non-cash consideration paid to contractors       620 321  
Non-cash minority equity investment       $ 50  
[1] On March 20, 2023, the Company made certain leadership changes in our essential oil business resulting in a change in strategy and outlook for the business which will result in a reduced portfolio offering. This reduction in the portfolio will be impactful to our essential oil business's future revenues and profitability and as a result the Company made revisions to our internal forecasts. The Company concluded that this change was an interim triggering event for the three months ending March 31, 2023 indicating the carrying value of our essential oil business's long-lived assets including trademarks may not be recoverable. Accordingly, the Company performed an interim impairment test of the trademark and assessed the recoverability of the related intangible assets by using level 3 inputs and comparing the carrying value of an asset group to the net undiscounted cash flow expected to be generated. The recoverability test indicated that certain definite-live trademark intangible assets were impaired. The Company concluded the carrying value of the trademark exceeded its estimated fair value which was determined utilizing the relief-from-royalty method to determine discounted projected future cash flows which resulted in an impairment charge. The Company recorded an intangible impairment charge of $16.7 million in the three months ending March 31, 2023 within impairment loss on intangibles on the condensed consolidated statement of operations.